Anti-IL5 and anti-IL5R-alpha Therapy in Patients with clinically significant Bronchiectasis and an eosinophilic Endotype: a retrospective Case Series

被引：0
|
作者：
Rademacher, J. [1 ]
Konwert, S. [1 ]
Fuge, J. [1 ]
Dettmer, S. [2 ]
Welte, T. [1 ]
Ringshausen, F. C. [1 ]
机构：
[1] Hannover Med Sch, Klin Pneumol, Hannover, Germany
[2] Hannover Med Sch, Inst Radiol, Inst Diagnost & Intervent Radiol, Hannover, Germany
来源：
PNEUMOLOGIE | 2020年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
FV225
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [1] Anti-IL5 and anti-IL5Rα therapy for clinically significant bronchiectasis with eosinophilic endotype: a case series
    Rademacher, Jessica
    Konwert, Stefanie
    Fuge, Jan
    Dettmer, Sabine
    Welte, Tobias
    Ringshausen, Felix C.
    EUROPEAN RESPIRATORY JOURNAL, 2020, 55 (01)
  • [2] German Asthma Net: Characterization of responders of anti-IL5 and anti-IL5(R) therapy
    Bal, Christina
    Milger, Katrin
    Skowasch, Dirk
    Schulz, Christian
    Jandl, Margret
    Schmidt, Olaf
    Ehmann, Rainer
    Stoshikj, Slagjana
    Zehetmayer, Sonja
    Taube, Christian
    Hamelmann, Eckard
    Buhl, Roland
    Korn, Stephanie
    Idzko, Marco
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [3] Change of Antibody Therapy in severe Eosinophilic Bronchial Asthma from Anti-IL5 to Anti-IL5 Receptor Antibodies
    Drick, N.
    Milger, K.
    Korn, S.
    Buhl, R.
    Schuhmann, M.
    Herth, F. J. F.
    Kendziora, B.
    Bergmann, K. C.
    Taube, C.
    Welte, T.
    Suhling, H.
    PNEUMOLOGIE, 2020, 74 : S9 - S10
  • [4] Anti-IL5/IL5R switching between biologics in patients with severe eosinophilic asthma
    Yilmaz, Insu
    Cetin, Gulden Pacaci
    Arslan, Bahar
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (07): : 1935 - 1936
  • [5] ANTI-IGE AND ANTI-IL5 THERAPY FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS
    Solans-Laque, Roser
    Fonseca, Eva
    Luis Callejas-Rubio, Jose
    Martinez-Zapico, Aleida
    Solanich, Xavier
    Miguel Lopez-Dupla, Jesu
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 812 - 813
  • [6] EFFECTIVENESS OF ANTI-IL4R THERAPY FOLLOWING SUBOPTIMAL RESPONSE TO ANTI-IL5/5R THERAPY IN SEVERE EOSINOPHILIC ASTHMA
    Mason, T. W.
    Hearn, A. P.
    d'Ancona, G.
    Fernandes, M.
    Roxas, C.
    Green, L.
    Thomson, L.
    Dhariwal, J.
    Nanzer, A. M.
    Jackson, D. J.
    THORAX, 2021, 76 : A177 - A178
  • [7] Effectiveness of Anti-IL4R Therapy Following Suboptimal Response to Anti-IL5/5R Therapy in Severe Eosinophilic Asthma
    Mason, T.
    Hearn, A. P.
    d'Ancona, G.
    Fernandes, M.
    Green, L.
    Roxas, C.
    Thomson, L.
    Dhariwal, J.
    Nanzer, A. M.
    Jackson, D. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [8] Reply to "Anti-IL5/IL5R switching between biologics in patients with severe eosinophilic asthma''
    Eger, Katrien
    Kroes, Johannes A.
    ten Brinke, Anneke
    Bel, Elisabeth H.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (07): : 1936 - 1936
  • [9] Anti-IL5 therapy for asthma and beyond
    Mukherjee, Manali
    Sehmi, Roma
    Nair, Parameswaran
    WORLD ALLERGY ORGANIZATION JOURNAL, 2014, 7
  • [10] A case of eosinophilic cystitis successfully treated with anti-IL5 monoclonal antibody
    Bertozzi, I
    Facchini, C.
    Parmigiani, A.
    Cinetto, F.
    Favero, E.
    Agostini, C.
    ALLERGY, 2020, 75 : 337 - 337
12345